Distribution and Antibiotic Resistance Pattern of Bacteria Isolated from Patients with Community-acquired Urinary Tract Infections in Iran: A Cross-sectional Study by Fallah 1, Fatemeh et al.
                              I J H S  
14       |        International Journal of Health Studies 2018;4(2) 
IJHS 2018;4(2):14-19 
ijhs.shmu.ac.ir doi: 10.22100/ijhs.v4i2.631 
Original Article 
International Journal of Health Studies 
Distribution and Antibiotic Resistance Pattern of Bacteria Isolated from the Patients 
with Community-Acquired Urinary Tract Infections in Iran: A Cross-Sectional Study 
Fatemeh Fallah1, Soha Parhiz1, Leila Azimi2, Marjan Rashidan3* 
1 Dept. of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 
2 Pediatric Infection Research Center, Research Institute for Children Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 
3 School of medicine, Shahroud University of Medical Sciences, Shahroud, Iran. 
Received: 10 July 2019  
Accepted: 30 July 2019 
Abstract 
Background: Urinary Tract Infections (UTIs) remain the common 
infections diagnosed in outpatients as well as hospitalized patients. 
Multi-Drug Resistance (MDR) and Extensively-Drug Resistance (XDR) 
in the bacteria is an alarming problem in the world. Thus, the present 
study was conducted to detect the etiologic agents associated with 
Community-Acquired Urinary Tract Infections (CA-UTIs) and 
investigate the antibiotic susceptibility patterns. 
Methods: This study was conducted on the outpatients referred to 
Labbafinejad Hospital Clinic, Tehran, Iran from September 2014 to 
March 2015. The bacterial pathogenic diversity was identified by 
standard laboratory methods. The antimicrobial resistance rates were 
determined by Kirby-Bauer disc diffusion method. 
Results: A total of 303 patients were enrolled in this study, among 
which 204 (67.3%) of them were female and 99 (32.5%) of them were 
male. Escherichia coli was the dominant species (69%), followed by 
Enterococcus faecalis (12.8%), and Klebsiella pneumoniae (4.6%). 
High resistance rate was observed to nalidixic acid (73.8%), 
trimethoprim/Sulfamethoxazole (54.3%), ciprofloxacin (54.3%) in E. 
coli, and tetracycline (89.7%) in E. faecalis strains as well as high 
susceptibility rate to meropenem (96.6%), imipenem (95.2%), amikacin 
(90.4%), cefoxtin (87.6%), and nitrofurantoin (82.8%) in E. coli, and 
nitrofurantoin (100%) in E. faecalis strains.In addition, 43.5% of the 
strains were found to be Multi-Drug-Resistant (MDR). 
Conclusions: The results of this study showed that, E. coli was the 
predominant uropathogen of CA-UTIs in this geographical area. It was 
also found that, the empirical treatment of urinary tract infections may 
be difficult due to high resistance to commonly used antibiotics. 
Continuous monitoring of MDR organisms and drug resistance 
patterns is needed to prevent treatment failure and reduce selective 
pressure. These findings suggest the use of nitrofurantoin, cefoxitin, 
and amikacin in this area of the country. 
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Introduction 
Urinary tract infections (UTIs) remain the common 
infections diagnosed in outpatients as well as hospitalized 
patients and the second most common cause of bacterial 
infection after respiratory tract in both settings. It is also 
estimated that, on a global scale, about 150 million people each 
year suffer from UTI and cost at least 6 billion dollars 
worldwide.1,2 UTI is defined by the presence of 105CFU/mL 
uropathogenic bacteria in urine and reported in both sexes and 
in all age groups. The risk for UTIs in females is greater than 
males because of sexual activity, pregnancy and the short 
anatomy of the urethra.3,4 In addition, long- term antibiotic use 
can also be increased the risk of UTIs. This could damage the 
periurethral flora and cause the establishment and infection of 
uropathogenic bacteria in the urinary tract.5,6 
Most previously reported studies have shown that 
Escherichia coli is often a causative agent of UTI in both 
hospital and community-acquired infections. Additionally, 
Enterococci, Klebsiella pneumonia, Streptococcus agalactiae, 
Proteus mirabilis, Pseudomonas aeruginosa, Citrobacter 
freundii, Enterobacter cloacae and Acinetobacter spp. are 
known as causative agents of UTI.7 
Given the rapid evolutionary adaptation strategies of 
bacteria, the antibiotic resistance patterns of the uropathogens 
in the recent years have also significantly changed, both in the 
community and hospital infections.8,9 
On the other hand, treatment of UTI in the community is 
usually performed empirically before the result of the 
microbiological test; this can lead to the development of 
antibiotic resistance and treatment failure.10 Furthermore, 
improper use of broad spectrum antimicrobial agents and poor 
infection control strategies, also contributes to increasing 
antibiotic resistance and the development of multi-drug 
resistant bacteria (MDR) in these patients, which has become a 
serious public health concern.11,12 Recent studies have also 
shown an increase in antibiotic resistance in Iran, which there 
is no regular monitoring of the use of broad- spectrum 
antibiotics, so identification of local etiologic agents of UTIs 
and examination of antibiotic resistance patterns are essential to 
guide clinicians in empirical treatment in this geographical 
area. Therefore, the aim of this study was to detection of 
etiologic agents associated with community-acquired urinary 
tract infections (CA-UTIs) and investigation of antibiotic 
susceptibility patterns. 
Materials and Methods  
Isolate Collection and Identification 
This cross-sectional descriptive study was conducted on the 
outpatients referred to Labbafinejad Hospital Clinic, Tehran, 
Iran from September 2014 to March 2015. Patients who treated 
with antibiotics or had a history of hospitalization were 
excluded from our study. 
A midstream clean-catch urine specimen was collected 
from the outpatients and was inoculated on the Blood and 
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MacConkey (Merck, Germany) agar plates using calibrated 
loops. For colony count, the plates were incubated at 37oC for 
24 hours. More than 105 colony -forming unit per milliliter was 
considered as bacteriuria. Then, the plates were transferred to 
the Pediatric Infections Research Center of Shahid Beheshti 
University of Medical Science at Mofid children's Hospital for 
further investigations. Identification of bacterial agents was 
done by conventional biochemical procedures in the patients.13 
All strains were stored at -70 oC in Trypticase Soy Broth 
(TSB) with 20% glycerol. 
Antibiotic susceptibility of the studied strains was 
determined by the standard Kirby-Bauer disk diffusion method 
on Muller Hinton agar medium (MHA, Merck, Germany). The 
antibiotic discs of cefepime (CPM, 30µg), piperacillin (PRL, 
100µg), ciprofloxacin (CIP, 5µg), amikacin (AK, 30µg), 
cefoxitin (FOX, 30µg), meropenem (MEM, 10µg), gentamicin 
(GEM, 10µg), ceftriaxone (CRO, 30µg), co-trimoxazole (SXT, 
1.25/23.75µg), nitrofurantoin (NIT, 300µg), cefuroxime 
(CXM, 30µg), imipenem (IMI, 10µg), nalidixic acid (NA, 
30µg), chloramphenicol (C, 30µg), ampicillin-sulbactam 
(SAM, 10µg), piperacillin-tazobactam (PTZ, 100µg), 
cefotaxime (CTX, 30µg), ceftazidime (CAZ, 30µg), ofloxacin 
(OFX, 5 µg), tigecycline (TGC, 15µg), ticarcillin (TIC, 75µg), 
aztreonam (ATM, 30µg), tobramycin (TOB, 10µg), 
clindamycin (CD, 2µg), erythromycin (ERY, 15µg), synercid 
(SYN, 15µg), linezolid (LZD, 30µg), ampicillin (AP, 10µg), 
tetracycline (TET, 30µg), minocycline (MN, 30µg), 
levofloxacin (LEV, 5µg), gatifloxacin (GAT, 5µg), 
vancomycine (VAN, 30µg), high-level gentamicin 
(GEM,120µg) and penicillin G (PEN, 10unit) were used 
(MAST group Ltd., United Kingdom) in this study. The results 
were interpreted according to the standard recommendation of 
the Clinical and Laboratory Standard Institute guidelines (CLSI 
2014).14 Control tests were conducted using reference strains of 
E. coli ATCC 25922, Staphylococcus aureus ATCC 25923, 
Streptococcus pneumonia ATCC 49619 and P. aeruginosa 
ATCC 27853. 
Statistical Analysis 
The data were analyzed using WHONET software 5.6 
provided by the World Health Organization for antimicrobial 
resistance surveillance of uropathogenic bacteria.15,16 Antibiotic 
resistance percentage and the rate of multi-drug resistance 
strains were also evaluated. According to the European Center 
for Disease Prevention and Control (ECDC) and the Centers 
for Disease Control and Prevention (CDC), multi-drug 
resistance strains are divided into MDR (Multiple Drug-
Resistant), XDR (Extensively Drug-Resistant) and PDR (Pan 
Drug-Resistant).17 MDR bacteria are defined as non-
susceptibility to at least one agent in 3 or more antimicrobial 
categories, XDRbacteria are defined as non-susceptibility to at 
least 1 agent in all but 2 or fewer antimicrobial categories and 
the PDR bacteria are defined as non-susceptibility to all agents 
in all antimicrobial categories. 
Results 
A total of 303 patients were enrolled in this study, 
including 204 (67.3%) females and 99 (32.5%) males with an 
age range from 4 to 90 years old. Hence, with respect to 
gender, females had a higher prevalence of infection than 
males. The prevalence of UTI was significantly associated with 
the gender (P.V=0.0001). 
Distribution of Uropathogenic Bacteria 
9 different species of bacteria were isolated from the urine 
samples with significant bacterial growth. 82.1 % of the 
isolates had Gram-negative bacteria while, only 17.7% of them 
had Gram-positive bacteria (table 1). E. coli was the most 
common bacteria isolated (N=210, 69%), followed by 
Enterococcus faecalis (N=39, 12.8%), and Klebsiella 
pneumonia (N=14, 4.6%). 
Table 1. Frequency of the isolated uropathogenic bacteria 
Antibiotic Resistance of Uropathogenic Bacteria 
Table 2 shows the prevalence of resistance among 
uropathogenic Gram-negative bacteria. E. coli showed the 
lowest resistance to meropenem (3.3%) and highest against 
nalidixic acid (73.8%). More than half of K. pneumonia were 
resistant to nitrofurantoin and piperacillin (57.1%) and 92.8% 
of them were sensitive to piperacillin/tazobactam. Proteus spp. 
was mostly resistant to trimethoprim/sulfamethoxazole, 
nitrofurantoin, nalidixic acid, and chloramphenicol (100%) and 
was also sensitive to piperacillin, amikacin, cefoxitin, 
meropenem, and cefuroxime (100%). Citrobacter spp. had 
100% susceptibility to cefepime, amikacin, gentamicin, 
trimethoprim/sulfamethoxazole, imipenem, nalidixic acid and 
piperacillin/tazobactam. The least effective antibiotic in this 
isolate was nitrofurantoin. Enterobacter spp. was generally 
resistant to most of our tested antibiotics. This isolate did not 
show resistance to antibiotics such as amikacin, cefoxitin, 
meropenem, nitrofurantoin, imipenem, and chloramphenicol. 
Edwardsiella spp. was generally susceptible to our tested 
antibiotics. The least effective antibiotics in this isolate were 
piperacillin, gentamicin, trimethoprim/sulfamethoxazole, and 
ampicillin/sulbactam. Acinetobacter spp. showed the highest 
resistance to ceftriaxone and cefotaxime (87.5%) and lowest 
against meropenem and imipenem (37.5%). P. aeruginosa 
exhibited the highest resistance to gentamicin (75%) and lowest 
against piperacillin, ciprofloxacin, and imipenem (12.5%). 
Table 2. Antibiotic resistance of uropathogenic Gram-
negative bacteria against tested antibiotics 
Table 1. Frequency of uropathogenic bacteria isolated 
Bacteria Frequency (%) Gram reaction (%) Total 
Escherichia coli 210 (69%) 
Gram-negative 
N= 249 (82.1%) 
303 
Klebsiella pneumonia 14 (4.6%) 
Acinetobacter spp. 8 (2.6%) 
Pseudomonas 
aeruginosa 8 (2.6%) 
Citrobacter spp. 4 (1.3%) 
Proteus spp. 3 (0.9%) 
Enterobacter sp. 1 (0.3%) 
Edwardsiella sp. 1 (0.3%) 
Streptococcus 
agalactieae 11 (3.6%) 
Gram-positive 
N= 54 (17.8%) Enterococcus spp.   E. faecalis 
 E. faecium 
39 (12.8%) 
4 (1.3%) 
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Table 3 shows the prevalence of resistance among ٠ 
uropathogenic Gram-positive bacteria. High levels of ١ 
tetracycline and minocycline resistance were observed in E. ٢ 
faecalis strains (89.7 and 87%). These strains did not show ٣ 
resistance to antibiotics such as vancomycin, nitrofurantoin, ٤ 
and linezolid. All 11 isolates of S. agalactiae were susceptible ٥ 
to erythromycin, ofloxacin, cefotaxime, ampicillin and ٦ 
linezolid and resistant to vancomycin.  ٧ 
Table 3. Antibiotic resistance of uropathogenic Gram-٨ 
positive bacteria against tested antibiotics ٩ 
Multi-Resistant Uropathogenic Bacteia ١٠ 
Phenotypic detection of multi-resistant strains was ١١ 
carried out by WHONET software 5.6 as MDR, possible ١٢ 
XDR or possible PDR (Figure 1). Among bacterial species ١٣ 
presented, Acinetobacter spp. showed the highest ١٤ 
percentage of MDR and XDR, 6(75%) and 5(62.5%) ١٥ 
isolates, respectively. Among a total of 233 isolates of ١٦ 
Enterobacteriaceae tested, 113 (48.4%) isolates were ١٧ 
found to be MDR, 9 (3.8%) isolates were possible XDR ١٨ 
and 1(0.4%) isolate was found to be PDR. In the Gram-١٩ 
positive bacteria, Enterococcus spp. showed 10(23.2%) ٢٠ 
isolates of MDR and 1 (2.3%) isolate of XDR. ٢١ 
MDR: Multi-Drug Resistant, Possible XDR; Extensively ٢٢ 
drug-resistant, Possible PDR; Pan drug-resistant ٢٣ 
Discussion ٢٤ 
Today, the increased antimicrobial resistance and the ٢٥ 
emergence of MDR bacteria causing CA-UTIs has become a ٢٦ 
serious public health concern resulting from the irrational and ٢٧ 
improper use of antimicrobials and the presence of antibiotics ٢٨ 
in the food chain.18 Thus, an amendment to the current ٢٩ 
antimicrobial stewardship program is needed in this ٣٠ 
geographical area to improve the efficacy of CA-UTIs ٣١ 
treatment.  ٣٢ 
In our study, the prevalence of UTI was significantly ٣٣ 
higher in females than males attributing to the physical and ٣٤ 
anatomical factors in females.3,4 These findings were in ٣٥ 
accordance with the findings of similar studies in CA-UTIs.19,20 ٣٦ 
 ٣٧ 
Table 2.Antibiotic resistance of uropathogenic Gram-negative bacteria against tested antibiotics 
Antibiotic disks 


















Piperacillin 147(70%) 8(57.1%) 0(0%) 2(50%) 1(100%) 1(100%) 5(62.5%) 1(12.5%) 
Ciprofloxacin 114(54.3%) 4(28.5%) 1(33.3%) 1(25%) 1(100%) 0(0%) 6(75%) 1(12.5%) 
Cefepime 50(23.8%) 3(21.4%) 1(33.3%) 0(0%) 1(100%) 0(0%) 8(100%) 3(37.5%) 
Amikacin 20(9.5%) 2(14.3%) 0(0%) 0(0%) 0(0%) 0(0%) 6(75%) 4(50%) 
Cefoxitin 26(12.4%) 3(21.4%) 0(0%) 1(25%) 0(0%) 0(0%) - - 
Meropenem 7(3.3%) 1(7.1%) 0(0%) 1(25%) 0(0%) 0(0%) 3(37.5%) 0(0%) 
Gentamicin 50(23.8%) 2(14.2%) 1(33.3%) 0(0%) 1(100%) 1(100%) 5(62.5%) 6(75%) 
Ceftriaxone 95(45.2%) 5(35.7%) 1(33.3%) 1(25%) 1(100%) 0(0%) 7(87.5%)  
Trimethoprim/Sulfamethoxazole 114(54.3%) 6(42.8%) 3(100%) 0(0%) 1(100%) 1(100%) 5(62.5%) - 
Nitrofurantoin 36(17.1%) 8(57.1%) 3(100%) 4(100%) 0(0%) 0(0%) 6(75%) - 
Cefuroxime 101(48.1%) 5(35.7%) 0(0%) 1(25%) 1(100%) 0(0%) 6(75%) - 
Imipenem 10(4.8%) 3(21.4%) 1(33.3%) 0(0%) 0(0%) 0(0%) 3(37.5%) 1(12.5%) 
Nalidixic Acid 155(73.8%) 5(35.7%) 3(100%) 0(0%) 1(100%) 0(0%) - - 
Chloramphenicol 20(9.5%) 3(21.4%) 3(100%) 1(25%) 0(0%) 0(0%) - - 
Ampicillin-sulbactam 90(42.9%) 5(35.7%) 2(66.7%) 1(25%) 1(100%) 1(100%) 5(62.5%) - 
Piperacillin/Tazobactam 16(7.6%) 1(7.1%) 1(33.3%) 0(0%) 1(100%) 0(0%) 0(0%) 0(0%) 
Cefotaxime - - - - - - 7(87.5%) 5(62.5%) 
Ofloxacin - - - - - - - 2(25%) 
Ceftazidim - - - - - - 5(62.5%) 5(62.5%) 
Tetracycline - - - - - - 6(75%) - 
Tigecycline - - - - - - 6(75%) - 
Ticarcillin - - - - - - - 3(37.5%) 
Aztreonam  - - - - - - - 3(37.5%) 
Tobramycin  - - - - - - - 5(62.5%) 
Table 3. Antibiotic resistance of uropathogenic Gram-positive bacteria 
against tested antibiotics 
Antibiotic disks 







Penicillin G 3(7.6%) 2(50%) - 
Vancomycin 0(0%) 1(25%) 11(100%) 
Tetracycline 35(89.7%) 2(50%) - 
Minocycline 34(87%) 2(50%) - 
Ciprofloxacin 10(25.6%) 2(50%) - 
Levofloxacin 9(23%) 2(50%) 0(0%) 
Gatifloxacin 9(23%) 2(50%) - 
Nitrofurantoin 0(0%) 1(25%)  
Gentamicin (120 µg) 14(35.8%) 1(25%) - 
Erythromycin - - 0(0%) 
Ofloxacin - - 0(0%) 
Cefotaxime - - 0(0%) 
Ampicillin 2 (5.1%) 2(50%) 0(0%) 
Linezolid 0(0%) 1(25%) 0(0%) 
Synercid  - - 1(9.09%) 
Clindamycin  - - 0(0%) 
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 ٣٨ 
Figure 1. Percentage of multi-drug resistance of uropathogenic bacteria. MDR; Multi-drug resistant, Possible XDR; Extensively drug-resistant, Possible PDR; Pan drug-resistant ٣٩ 
 ٤٠ 
Enterobacteriaceae are the most common cause of UTI in 
hospitals and the community, and are responsible for many 
current problems caused by transferable multi-antibiotic 
resistance.21 Therefore, the ability to monitor the antimicrobial 
resistance trends in infections most commonly caused by these 
organisms, across all patient groups will provide valuable 
additional insight needed to inform public health action. In this 
study, the Gram-negative bacilli accounted for 84.43% of the 
total bacterial isolates, while Gram-positive cocci accounted for 
15.57% of the total bacterial isolates. As expected, E. coli was 
the most prevalent uropathogen (69%) in CA-UTIs. This 
finding is in agreement with the previous studies conducted in 
Iran (51.5%),22 as well as European studies (76%)23 and studies 
carried out in Germany (74.5%)24 and Denmark25 but is higher 
than the reports from Ethiopia (39.4%)26 and Nigeria 
(40.7%).27 In this study, E. faecalis was the second predominate 
isolate accounting for 12.8% of the total bacterial isolates. This 
result was consistent with a similar study conducted in India20 
and Korea28 and was contrary to other studies.11,29,30 The 
similarities and differences in the type and distribution of 
uropathogens may be related to various environmental 
conditions and host factors and practices, such as health and 
educational programs and social and economic hygiene 
standards in each country. 
Understanding the antibiotic resistance patterns in E. coli, 
as the most frequent uropathogen is important to choose an 
empirical antimicrobial therapy. As shown in table 2, E. coli 
showed high level of resistance to nalidixic acid (73.8%) and 
piperacillin (70%) followed by ciprofloxacin and 
trimethoprim/sulfamethoxazole (54.3%). The current results 
are similar to the previous studies conducted on CA-UTIs in 
Iran31,32 and are less than that reported in other surveys 
performed in other parts of the world.33-36 
On the other hand, ciprofloxacin and 
trimethoprim/sulfamethoxazole are used as a first -choice 
treatment for CA-UTIs in our region. The widespread use of 
these antimicrobials in the treatment of community-acquired 
infections may have contributed to the high levels of observed 
resistance. Therefore, these antibiotics should be carefully 
considered for empirical treatment. Maximum sensitivity was 
reported towards meropenem (96.6%), imipenem (95.2%), 
piperacillin/tazobactam (92.3%), chloramphenicol (90%) and 
amikacin (90.4%) followed by cefoxitin (87.6%), 
nitrofurantoin (82.8%), gentamicin and cefepime (76%). 
Similar results were reported in the studies conducted in other 
countries.34,37,38 In another study, E. coli strains were highly 
resistant against cefepime (85%) and nitrofurantoin (80%) 
followed by cefoxitin (69%), gentamicin (64%) and amikacin 
(51%).39 Therefore, our findings suggest that, nitrofurantoin is 
an appropriate empirical choice for treatment of CA-UTIs in 
this region. In this regards, different patterns of antimicrobial 
resistance in different regions may be due to the regional 
variation in antibiotic practice patterns. 
In this study, the highest percentage of E. faecalis isolates 
was resistant to Tetracyclines (tetracycline, 89.7 and 
minocycline, 87%). This frequency was similar to the 
resistance rates reported in Taiwan (91.8%),40 Iran (90.3%)41 
and Iraq (100%),42 but higher than those reported in India 
(50%) and Brazil (59.2%).40,43 The high-level resistance to 
Tetracyclines in these strains may be attributed to the overuse 
of antibiotics to treat human diseases and livestock in Iran.44 
Therefore, it is necessary to monitor the use of the 
antimicrobial in the community and to evaluate animal 
reservoirs of tetracycline-resistant E. faecalis strains. The most 
susceptibility was observed to vancomycin, nitrofurantoin, 
linezolid, ampicillin, and penicillin. The high susceptibility to 
these antibiotics, making them the first line of treatment for 
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CA-UTIs, as long as, the microbiological information is 
known. 
Among 302 isolates, 43.5% of them were found to be 
multi-drug resistant. In this survey, a significant higher 
percentage of MDR and the possible XDR strains from CA-
UTIs was observed. Among the tested uropathogens, 
Acinetobacter spp. exhibited the highest rates of MDR and the 
possible XDR followed by E. coli and P. aeruginosa. In our 
report, only K. pneumonia isolates were found to be the 
possible PDR phenotype. The contributing factors for the 
emergence of such a high bacterial antibiotic resistance in CA-
UTIs may be the use of antibiotics in livestock, self-
medication, excessive availability of antibiotics, dispensing 
them without proper prescriptions, non-compliance with an 
antibiotic regimen by patients, and indiscriminate use of 
antibiotics. The involvement of such drug-resistant bacteria in 
the development of community-acquired infections is a very 
serious concern in terms of public health. Therefore, some 
necessary steps should be taken immediately to control the 
situation. 
The results of the current study showed an overview of the 
species diversity of the uropathogenic bacteria and antibiotic 
resistance patterns in Iran’s̓ community. A high prevalence of 
multi-drug resistance and the possible XDR strains were 
observed among uropathogenic bacteria. In particular, 
resistance to nalidixic acid, cotrimoxazole and ciprofloxacin 
was higher, thus the use of these drugs should be avoided for 
empirical UTI-based treatment. In such cases, empirical 
treatment with nitrofurantoin, cefoxitin and amikacin may 
provide better antibiotic coverage. These findings suggest the 
need for continuous antimicrobial surveillance of multi-drug 
resistance uropathogenic bacteria to fight the UTI caused by 
these bacterial pathogens. 
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